Deep Track Capital, LP Nektar Therapeutics Call Options Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
Call Options
2 transactions
Others Institutions Holding NKTR
# of Institutions
147Shares Held
138MCall Options Held
32.6KPut Options Held
14.1K-
Black Rock Inc. New York, NY15.2MShares$10 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$8.14 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA9.4MShares$6.2 Million0.22% of portfolio
-
Samlyn Capital, LLC New York, NY9.2MShares$6.07 Million0.19% of portfolio
-
Acadian Asset Management LLC Boston, MA7.2MShares$4.75 Million0.02% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $124M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...